On the occasion of the 2026 World Malaria Day, Ana Paula Arez, member of the VBD-GHTM Research Group, participated in the RTP África programme Causa e Efeito to discuss the current state of malaria in Africa, ongoing scientific advances, and the global challenges surrounding the disease.
The special edition of the programme brought together researchers, physicians, and public health experts to reflect on progress in malaria prevention, diagnosis, and treatment, while also addressing persistent inequalities in access to healthcare and the impact of the disease across endemic regions.
During the debate, Ana Paula Arez highlighted the importance of sustained investment in research, surveillance, and international cooperation to tackle malaria effectively. She also reinforced the need for integrated approaches combining science, public health policies, and community engagement.
Her participation contributed to a broader discussion on the future of malaria control, including emerging scientific innovations, vector monitoring, and the importance of strengthening healthcare systems in vulnerable regions.
Observed annually on 25 April, World Malaria Day aims to raise awareness and mobilize efforts towards the prevention, control, and eventual elimination of malaria worldwide. According to the World Health Organization, malaria continues to disproportionately affect populations in sub-Saharan Africa, particularly children and pregnant women.
The full programme is available on RTP Play through this link.
This article is published as part of the World Malaria Day 2026 celebrations. To learn more about our work on malaria, see our related news:
GHTM marks World Malaria Day 2026, highlighting research innovation in the fight to end malaria
World Malaria Day 2026: Advancing Innovation for Faster and More Accessible Malaria Diagnosis
